biotech / news / / Livemint
Lilly announced a partnership with chip-maker Nvidia in October to build what it called the industry’s most powerful supercomputer.
Lilly and Roche are building industry-leading supercomputers with Nvidia partnerships to accelerate AI drug discovery.
KEY POINTS
- Takeda's AI-discovered psoriasis pill has succeeded in trials and is being submitted for U.S. approval this year.
- AI's biggest pharma impact so far is in manufacturing and operations, not novel drug discovery breakthroughs.
- Lilly used machine learning 'digital twins' to significantly boost production of its weight loss drug tirzepatide.
- Analysts estimate AI could save U.S. pharma $90 billion over five years, raising per-share profits by up to 13%.
COMPANIES
Summarized by Newsio from Livemint. How we summarize →